Multiple outlets report on Kylie Minogue’s experience of breast cancer recurrence and explain why relapses can occur even after treatment. The articles discuss that recurrence risk varies by cancer type, stage at diagnosis, and the treatments used, including surgery, chemotherapy, radiation and hormone or targeted therapies. They also describe how some tumours or microscopic disease can persist in the body after treatment, remaining too small to be found on scans or blood tests. When those remaining cells later grow, the cancer becomes detectable again, leading to a “relapse.” The coverage notes that advances in imaging and testing reduce detection limits, but they do not eliminate the possibility of very small disease going unnoticed. Sources also outline that relapse can reflect the underlying biology of the cancer, including factors that influence how aggressive it is and how likely it is to spread. Overall, the reporting frames recurrence as a known outcome for some breast cancers, with timing and frequency dependent on individual clinical circumstances, rather than a single cause.